info@birdgroup.be

Login

Research papers

Inflamm Bowel Dis . 2025 Oct 1;31(10):2615-2664. doi: 10.1093/ibd/izaf171.
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease

Lancet Gastroenterol Hepatol. 2025 Oct 27:S2468-1253(25)00233-X. doi: 10.1016/S2468-1253(25)00233-X
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study

The Lancet Gastroenterology & Hepatology, Volume 10, Issue 10, October 2025, 882 - 895
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2))

Journal of Crohn's and Colitis Volume 19, Issue 7 July 2025
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease

The Lancet Gastroenterology & Hepatology, Volume 10, Issue 9, 818 - 830
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD)

Lancet Gastroenterol Hepatol . 2025 Jun;10(6):550-561. DOI: 10.1016/S2468-1253(25)00026-3
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE)

Gut Published Online First: 30 April 2025. doi: 10.1136/gutjnl-2025-335023
British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease

PLoS Genet . 2025 Apr 10;21(4):e1011599. doi: 10.1371/journal.pgen.1011599
The identification of blood-derived response eQTLs reveals complex effects of regulatory variants on inflammatory and infectious disease risk

1
2
3
4
5
›